Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Shares Issued (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Shares Issued for 4 consecutive years, with $2000.0 as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 103.85% to $2000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $5000.0 for FY2025, N/A changed from the prior year.
  • Shares Issued for Q4 2025 was $2000.0 at Spruce Biosciences, down from $3000.0 in the prior quarter.
  • The five-year high for Shares Issued was $180000.0 in Q1 2024, with the low at -$128000.0 in Q3 2024.
  • Average Shares Issued over 4 years is $1625.0, with a median of $2000.0 recorded in 2022.
  • The sharpest move saw Shares Issued soared 500.0% in 2023, then skyrocketed 102.34% in 2025.
  • Over 4 years, Shares Issued stood at -$2000.0 in 2022, then skyrocketed by 500.0% to $8000.0 in 2023, then tumbled by 750.0% to -$52000.0 in 2024, then surged by 103.85% to $2000.0 in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $2000.0, $3000.0, and -$52000.0 for Q4 2025, Q3 2025, and Q4 2024 respectively.